The glycine antagonist (+)-HA-966 injected into the nucleus accumbens stimulates locomotion in mice. Rapid communication

Journal of Neural Transmission

Volumn 104, Issue 4-5, 1997, Pages 419-425

  Nilsson, M ^a   Carlsson, M L ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Department of Pharmacology ^*  (Sweden)

Author keywords

(+) HA 966; Glycine; Locomotion; Mouse; NMDA; Schizophrenia

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; GLYCINE RECEPTOR; GLYCINE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENANTIOMER; HABITUATION; INTRACEREBRAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; STEREOCHEMISTRY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCINE; INJECTIONS; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PYRROLIDINONES; STEREOISOMERISM;

EID: 0030750839     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01277660     Document Type: Article

References (23)

1. Bristow LJ, Hutson PH, Thorn L, Tricklebank MD (1993) The glycine/NMDA receptor antagonist, (+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Br J Pharmacol 108: 1156-1163
2. Bristow LJ, Flatman KL, Hutson PH, Kulagowski JJ, Leeson PD, Young L, Tricklebank MD (1996) The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist L-701,324 in rodents. J Pharmacol Exp Ther 277:578-585
3. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci 13: 272-276
4. Carlsson ML (1993) Hypothesis - Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? J Neural Transm [GenSect] 94: 1-10
5. Carlsson ML, Engberg G, Carlsson A (1994) Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice. J Neural Transm [GenSect] 95: 223-233
6. Carroll CB, Hollay V, Brotchie JM, Mitchell IJ (1995) Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms. Psychopharmacology 119: 55-65
7. Cascella NG, Macciardi F, Cavallini C, Smeraldi E (1994) d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study. J Neural Transm [GenSect] 95: 105-111
8. Grane GE (1959) Cycloserine as an antidepressant agent. Am J Psychiatry 115: 1025-1026
9. Goff DC, Tsai G, Manoach DS, Coyle JT (1995) Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry 152: 1213-1215
10. Henderson G, Johnson JW, Ascher P (1990) Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor. J Physiol 430: 189-212
11. Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Horowitz A, Kelly D (1996) Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br J Psychiatry 169: 610-617
12. Hood WF, Compton RP, Monahan JB (1989) D-Cycloserine: a ligand for the N-methy-D-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci Lett 98: 91-95
13. Kretschmer BD, Schmidt WJ (1996) Behavioral effects mediated by the modulatory glycine site of the NMDA receptor in the anterodorsal striatum and nucleus accumbens. J Neurosci 16: 1561-1569
14. Lehmann J, Colpaert F, Canton H (1991) Glutamate and glycine co-activate while polyamines merely modulate the NMDA receptor complex. Prog Neuropsychopharmacol Biol Psychiatry 15: 183-190
15. Lewis WC, Calden G, Thurston JR, Gilson WE (1957) Psychiatric and neurologic reactions to cycloserine in the tretament of tuberculosis. Dis Chest 32: 172-182
16. Naquet R, Resende J, Brouillet F, Soulayrol R (1958) Troubles neuro-psychiques et modifications electroencephalographiques au cours du traitement de la tuberculose pulmonaire par la cycloserine. Ann Méd-Psych 116: 462-472
17. Pullan LM, Britt M, Chapdelaine MJ, Keith RA, LaMonte D, Mangano TJ, Patel J, Powel RJ, Stumpo RJ, Warwick PJ, Zinkand WC, Salama AI (1990) Stereoselectivity for the (R)-enantiomer of HA-966 (1-hydroxy-3-aminopyrrolidone-2) at the glycine site of the N-methyl-D-aspartate receptor complex. J Neurochem 55: 1346-1351
18. Reynolds IJ, Miller RJ (1988) Multiple sites for the regulation of the N-methyl-D-aspartate receptor. Mol Pharmacol 33: 581-584
19. Slotnick BM, Leonard CM (1975) A stereotaxic atlas of the albino mouse forebrain. US Department of Health, Education and Welfare
20. Stauch Slusher B, Rissolo KC, Jackson PF, Pullan LM (1994) Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice. J Neural Transm 97: 175-185
21. Thomson AM (1990) Glycine is a coagonist at the NMDA receptor/channel complex. Prog Neurobiol 35: 53-74
22. Vallade L, Hugonenq H, Jude J-P (1959) La neuro-toxicité de la cycloserine. La Presse Medicale 67: 138-140
23. Witkin JM (1993) Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists. Life Sci 53: 405-410